VEDBAEK, Denmark, May 15, 2009 (GLOBE NEWSWIRE) -- Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”), today reported 69% growth in revenue for the first quarter of 2009 compared to the same period last year. New product launches and market growth supports Exiqon’s expectations of continued solid revenue growth through 2009. Operational initiatives have been implemented to improve the company’s cash flow. Exiqon’s full-year revenue guidance is revised from DKK 175-200 million to DKK 165-190 million attributable to Exiqon Life Sciences but guidance is otherwise maintained.
